NOVEL NANOPARTICLE-BASED DELIVERY OF H3.3K27M PEPTIDE TO TUMOR-ASSOCIATED MACROPHAGES ENHANCES THE TUMOR HOMING OF H3.3K27M-TCR TRANSDUCED T-CELLS IN HLA-A2/DR1 TRANSGENIC MICE WITH H3.3K27M+

被引：0
|
作者：
Yamamichi, Akane [1 ]
Chuntova, Polly [1 ]
Kakihara, Bunta [2 ]
Chen, Tiffany [1 ]
Diebold, David [1 ]
Harada, Naozumi [3 ]
Akiyoshi, Kazunari [4 ]
Shiku, Hiroshi [5 ]
Okada, Hideho [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Kansai Denryoku Hosp, Osaka, Japan
[3] United Immun Co Ltd, Tsu, Mie, Japan
[4] Kyoto Univ, Grad Sch Engn, Kyoto, Japan
[5] Mie Univ, Grad Sch Med, Tsu, Mie, Japan
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IMMU-08
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [1] Identification of a novel and a shared H3.3K27M mutation derived neoantigen epitope and H3.3K27M specific TCR engineered T cell therapy for glioma
    Chheda, Zinal
    Kohanbash, Gary
    Sidney, John
    Okada, Kaori
    Jahan, Naznin
    Carrera, Diego
    Watchmaker, Payal
    Downey, Kira
    Liu, Shuming
    Shrivastav, Shruti
    Mueller, Sabine
    Pollack, Ian F.
    Carcaboso, Angel M.
    Sette, Alessandro
    Hou, Yafei
    Okada, Hideho
    CANCER RESEARCH, 2017, 77
  • [2] H3.3K27M ENHANCES SENSITIVITY TO ATR INHIBITION IN PEDIATRIC GLIOMA
    Wang, Heng
    Kaplan, Jakub P.
    Chowdhury, Dipanjan
    Pal, Sharmistha
    Haas-Kogan, Daphne
    NEURO-ONCOLOGY, 2024, 26
  • [3] PNOC007: H3.3K27M SPECIFIC PEPTIDE VACCINE COMBINED WITH POLY-ICLC FOR THE TREATMENT OF NEWLY DIAGNOSED HLA-A2+ H3.3K27M MIDLINE GLIOMAS
    Mueller, Sabine
    Lulla, Rishi
    Goldman, Stewart
    Banerjee, Anu
    Chi, Susan
    Whipple, Nicholas
    Crawford, John
    Gauvain, Karen
    Nazemi, Kellie
    Nazarian, Javad
    Taitt, Jared
    Watchmaker, Payal
    Nejo, Takahide
    Okada, Kaori
    Butterfield, Lisa
    Molinaro, Annette
    Prados, Michael
    Okada, Hideho
    NEURO-ONCOLOGY, 2019, 21 : 284 - 285
  • [4] IMMUNE PROFILES ASSOCIATE WITH OUTCOMES IN HLA-A*02:01+, H3.3K27M+ PATIENTS WITH DIFFUSE MIDLINE GLIOMAS TREATED WITH H3.3K27M PEPTIDE VACCINE COMBINED WITH POLY-ICLC: A PNOC REPORT
    Mueller, Sabine
    Taitt, Jared M.
    Villanueva-Meyer, Javier
    Bonner, Erin R.
    Nejo, Takahide
    Lulla, Rishi R.
    Goldman, Stewart
    Banerjee, Anurhada
    Chi, Susan
    Whipple, Nicholas S.
    Crawford, John R.
    Gauvain, Karen
    Nazemi, Kellie
    Watchmaker, Payal
    Almeida, Neil D.
    Okada, Kaori
    Salazar, Andres
    Gilbert, Ryan
    Nazarian, Javad
    Molinaro, Annette
    Butterfield, Lisa H.
    Prados, Michael
    Okada, Hideho
    NEURO-ONCOLOGY, 2020, 22 : 63 - 63
  • [5] H3K27ME3-MEDIATED SILENCING TUMOR SUPPRESSORS SUPPORTS THE PROLIFERATION OF PEDIATRIC BRAIN TUMOR CELLS HARBORING THE H3.3K27M MUTATION
    Fang, Dong
    Gan, Haiyun
    Cheng, Liang
    Lee, Jeong-Heon
    Zhou, Hui
    Sarkaria, Jann
    Daniels, David
    Zhang, Zhiguo
    NEURO-ONCOLOGY, 2017, 19 : 20 - 20
  • [6] PNOC007: H3.3K27M SPECIFIC PEPTIDE VACCINE COMBINED WITH POLY-ICLC FOR THE TREATMENT OF NEWLY DIAGNOSED HLA-A2+H3.3K27M DIFFUSE MIDLINE GLIOMAS (DMG)
    Mueller, Sabine
    Taitt, Jared
    Bonner, Erin
    Lulla, Rishi
    Goldman, Stewart
    Banerjee, Anu
    Chi, Susan
    Whipple, Nicholas S.
    Crawford, John
    Gauvain, Karen
    Nazemi, Kellie
    Watchmaker, Payal
    Nejo, Takahide
    Okada, Kaori
    Butterfield, Lisa H.
    Nazarian, Javad
    Villaneuva-Meyer, Javier
    Molinaro, Annette M.
    Prados, Michael
    Okada, Hideho
    NEURO-ONCOLOGY, 2020, 22 : 366 - 366
  • [7] CRISPR BASED GENOME EDITING OF HUMAN T CELLS TO TARGET H3.3K27M MUTATION IN GLIOMAS
    Hegde, Bindu
    Roth, Theodore
    Nguyen, David
    Chheda, Zinal
    Apathy, Ryan
    Marson, Alex
    Okada, Hideho
    NEURO-ONCOLOGY, 2019, 21 : 127 - 127
  • [8] AN H3.3K27M LONG PEPTIDE VACCINE INDUCES EXPANSION OF SPECIFIC CD4 AND CD8 T CELL CLONES IN A PATIENT WITH PROGRESSIVE H3.3K27M-MUTANT MIDLINE GLIOMA
    Sahm, K.
    Mildenberger, I.
    Bunse, L.
    Green, E.
    Wick, W.
    Platten, M.
    NEURO-ONCOLOGY, 2018, 20 : 264 - 264
  • [9] PRC2-indepdendent actions of H3.3K27M in embryonic stem cell differentiation
    Cohen, Lea R. Z.
    Kaffe, Binyamin
    Deri, Eden
    Leibson, Chen
    Nissim-Rafinia, Malka
    Maman, Moria
    Harpaz, Nofar
    Ron, Guy
    Shema, Efrat
    Meshorer, Eran
    NUCLEIC ACIDS RESEARCH, 2023, 51 (04) : 1662 - 1673
  • [10] H3.3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma
    Immisch, Lena
    Papafotiou, George
    Popp, Oliver
    Mertins, Philipp
    Blankenstein, Thomas
    Willimsky, Gerald
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (10)
12345